verapamil has been researched along with Diabetic Angiopathies in 7 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a prospective study of 809 patients with stable angina pectoris randomized to receive metoprolol or verapamil, a subgroup of 69 diabetic patients was compared with non-diabetic patients with respect to the risk of cardiovascular (CV) death, non-fatal myocardial infarction (MI) and revascularization." | 3.73 | The impact of diabetes or elevated fasting blood glucose on cardiovascular prognosis in patients with stable angina pectoris. ( Björkander, I; Forslund, L; Held, C; Hjemdahl, P; Rehnqvist, N, 2005) |
| "A total of 898 men and women with type 2 diabetes mellitus and hypertension, receiving antihypertensive treatment with one single drug and whose BP was > 140 and/or 90 mmHg." | 2.69 | Prospective comparison of therapeutical attitudes in hypertensive type 2 diabetic patients uncontrolled on monotherapy. A randomized trial: the EDICTA study. ( Coca, A; de la Cámara, AG; de la Figuera, M; de la Sierra, A; Fernández, R; Garrido, J; Luque-Otero, M; Moreno, E; Ruilope, LM, 1999) |
| " Forearm blood flow was determined by venous occlusion plethysmography, and dose-response curves were generated for each drug." | 1.29 | Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. ( Creager, MA; Creager, SJ; Cusco, JA; Johnstone, MT; Lee, BK; Scales, KM, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walczak, IM | 1 |
| Hjemdahl, P | 2 |
| Eriksson, SV | 1 |
| Held, C | 2 |
| Forslund, L | 2 |
| Näsman, P | 1 |
| Rehnqvist, N | 2 |
| Björkander, I | 1 |
| Sharma, SK | 1 |
| Ruggenenti, P | 1 |
| Remuzzi, G | 1 |
| Johnstone, MT | 1 |
| Creager, SJ | 1 |
| Scales, KM | 1 |
| Cusco, JA | 1 |
| Lee, BK | 1 |
| Creager, MA | 1 |
| Gordon, EA | 1 |
| Guppy, LJ | 1 |
| Ruilope, LM | 1 |
| de la Sierra, A | 1 |
| Moreno, E | 1 |
| Fernández, R | 1 |
| Garrido, J | 1 |
| de la Figuera, M | 1 |
| de la Cámara, AG | 1 |
| Coca, A | 1 |
| Luque-Otero, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effects of Watermelon Juice Supplementation on Postprandial Vascular Endothelial Function and Blood Flow During Hyperglycemia: A Pilot Study[NCT04092439] | 18 participants (Actual) | Interventional | 2019-09-12 | Completed | |||
| The Effect of Type 1 Diabetes on Pan-Arterial Vascular Function and Insulin Sensitivity in Humans[NCT02490124] | 7 participants (Actual) | Observational | 2014-12-31 | Completed | |||
| The Impact of Fitness and Mineralocorticoid Receptor Blockade on Vascular Dysfunction in Adults With Type 1 Diabetes[NCT03174288] | 32 participants (Actual) | Interventional | 2015-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for verapamil and Diabetic Angiopathies
| Article | Year |
|---|---|
Managing hypertension in diabetic patients--focus on trandolapril/verapamil combination.
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetic Angiopathies; Drug Thera | 2007 |
2 trials available for verapamil and Diabetic Angiopathies
| Article | Year |
|---|---|
Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS).
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Death, Sudden, Cardiac; Diab | 2006 |
Prospective comparison of therapeutical attitudes in hypertensive type 2 diabetic patients uncontrolled on monotherapy. A randomized trial: the EDICTA study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Attitude to Health; Blood P | 1999 |
4 other studies available for verapamil and Diabetic Angiopathies
| Article | Year |
|---|---|
Diabetes technology news. Calcium antagonists aid high blood pressure control.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Diabetic Angiopa | 2003 |
The impact of diabetes or elevated fasting blood glucose on cardiovascular prognosis in patients with stable angina pectoris.
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Blood Glucose; Cardiovascular Diseases; Diabetic Angiopathi | 2005 |
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Topics: Adult; Blood Flow Velocity; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothe | 1993 |
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Topics: Adult; Blood Flow Velocity; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothe | 1993 |
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Topics: Adult; Blood Flow Velocity; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothe | 1993 |
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Topics: Adult; Blood Flow Velocity; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothe | 1993 |
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Topics: Adult; Blood Flow Velocity; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothe | 1993 |
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Topics: Adult; Blood Flow Velocity; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothe | 1993 |
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Topics: Adult; Blood Flow Velocity; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothe | 1993 |
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Topics: Adult; Blood Flow Velocity; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothe | 1993 |
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Topics: Adult; Blood Flow Velocity; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothe | 1993 |
Cardiomyopathic changes in streptozotocin-induced diabetes.
Topics: Adenosine Triphosphatases; Animals; Body Weight; Calcium Channel Blockers; Cardiomyopathies; Cardiot | 1999 |